IGF-LR3 (Insulin-Like Growth Factor Long R3) is a synthetic analogue of the naturally occurring growth peptide IGF-1. It is manufactured in peptide laboratories and supplied in high-purity lyophilised powder form for investigational research.

IGF-LR3 has been engineered with an extended amino-acid sequence that gives it a significantly longer half-life than standard IGF-1, making it valuable for controlled experimental models. Scientific investigations have focused on its ability to bind IGF-1 receptors and remain active in cellular systems for prolonged study periods.

Available research data, primarily from in-vitro and animal studies, indicates IGF-LR3 may assist researchers examining:

• Cellular growth and proliferation mechanisms
• Muscle and connective-tissue regeneration models
• Interaction of IGF peptides with metabolic pathways
• Receptor-binding dynamics at the IGF-1 receptor
• Laboratory investigation of growth-factor stability and duration of action

Because of its extended activity profile, IGF-LR3 is widely utilized by private research institutions exploring non-therapeutic applications related to performance and tissue-recovery experiments.performance and recovery research.

Intended Use: Product supplied strictly as an investigational research compound. It is not approved by the FDA, TGA, or any regulatory authority for therapeutic, diagnostic, or medicinal use. Not for human or animal consumption.